HealthQuill Medical
The human brain didn’t evolve as one single unit, but as two distinct organs independently, Stanford researchers found — a discovery that holds promise to fight brain stem diseases such as spinal muscular atrophy and amyotrophic lateral sclerosis.
Health Medical Research

Human brain is not a single unit,  they are two: Stanford researchers find

HQ Team September 23, 2026: The human brain didn’t evolve as one single unit, but as two distinct organs independently, Stanford researchers found.

Read More
Novo Nordisk A/S or Novo, has partnered with UNICEF to expand their global partnership for four years to fight childhood overweight and obesity, and the Danish company has committed $18 million until 2030.
Drugs Health Medical

Novo-UNICEF extends pact to fight child obesity, Novo to pump in $18m

HQ Team September 23, 2026: Novo Nordisk A/S or Novo, has partnered with UNICEF to expand their global partnership for four years to.

Read More
British pharmaceutical company GSK Plc said a new experimental cancer drug helped patients with a difficult-to-treat type of lung cancer live longer than those who received an existing treatment, according to a company statement.
Drugs Medical Pharma

GSK’s test drug cuts death risk by 54% in patients with small lung cancer relapse

HQ Team September 13, 2026:  British pharmaceutical company GSK Plc said a new experimental cancer drug helped patients with a difficult-to-treat type of.

Read More
AstraZeneca’s end-stage trial of an experimental drug to treat breast cancer failed to prolong a patient’s life without the disease progressing or getting worse, according to the Anglo-Swedish company.
Drugs Medical Pharma

AstraZeneca’s test drug for breast cancer fails to prolong life

HQ Team September 13, 2026: AstraZeneca’s end-stage trial of an experimental drug to treat breast cancer failed to prolong a patient’s life without.

Read More
AbbVie Inc.’s experimental drug has reduced the number of migraine days during the menstrual period, meeting a key goal in late-stage trials, the company announced.
Drugs Medical Pharma

AbbVie’s late-stage experimental drug reduces menstrual migraine days

HQ Team September 11, 2026: AbbVie Inc.’s experimental drug has reduced the number of migraine days during the menstrual period, meeting a key.

Read More
A team of neurosurgeons, medical robotics specialists, and advanced energy systems engineers is building  a device that uses high-intensity sound waves to break down targeted diseased tissue without incisions, heat, or trauma, enabling the body to heal itself naturally.
Drugs Medical Pharma

US-based start-up developing medical device to replace surgical incision

HQ Team September 10, 2026: A team of neurosurgeons, medical robotics specialists, and advanced energy systems engineers is building  a device that uses.

Read More
Novartis AG’s experimental drug to treat a neuromuscular disease failed to meet its target, the company announced.
Drugs Medical Pharma

Novartis’s neuromuscular experimental drug fails to meet targets

HQ Team September 9, 2026: Novartis AG’s experimental drug to treat a neuromuscular disease failed to meet its target, the company announced. The.

Read More
An outbreak of the Bundibugyo species of Ebola, which has no approved vaccines or treatments, has killed 2,325 people, becoming the deadliest in the central African country of the Democratic Republic of Congo.
Drugs Health Medical

Ebola virus becomes deadliest outbreak in Congo, still ‘moving fast’

HQ Team August 17, 2026: An outbreak of the Bundibugyo species of Ebola, which has no approved vaccines or treatments, has killed 2,325.

Read More
US FDA clears Abbott Laboratories' new software to clear heart blockages.
Health Medical Pharma

Abbott gets FDA nod for software to help doctors open blocked arteries

May 3, 2026: The US Food and Drug Administration has cleared Abbott Laboratories’ new artificial-intelligence-powered software for coronary imaging, enabling doctors to have.

Read More
Pfizer Inc. and France-based Valneva SE's investigational vaccine has shown 70% efficacy in preventing Lyme disease in individuals aged five and above.
Drugs Medical Pharma

Pfizer, Valneva’s experimental Lyme disease vaccine shows 70% efficacy

HQ Team March 25, 2026: Pfizer Inc. and France-based Valneva SE‘s investigational vaccine has shown 70% efficacy in preventing Lyme disease in individuals.

Read More